Johanna Friedl-Naderer, Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN), sold 1,085 shares at $24.35 ($25K) on 2026-09-04, disclosed to the SEC on 2026-09-08.
Scheduled sale ($25k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.35 | 900 | $22K | 86.3% |
| 2 | $18.88 | 185 | $3K | 13.7% |
| Total | $23.42 avg | 1,085 | $25K | 100% |
| Filing → |
| DYN | SELL | 2026-05-14 | $4K | — | Filing → |
| DYN | SELL | 2026-03-06 | $2K | — | Filing → |
| DYN | SELL | 2025-12-05 | $3K | — | Filing → |